Do Traders Think Agile Therapeutics Inc (AGRX) Can Keep Climbing Monday?

Agile Therapeutics Inc (AGRX) stock is up 20.00% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Agile Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on AGRX!

See Full AGRX Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With AGRX Stock Today?

Agile Therapeutics Inc (AGRX) stock is trading at $0.18 as of 2:05 PM on Monday, Apr 18, a rise of $0.02, or 12.74% from the previous closing price of $0.16. The stock has traded between $0.16 and $0.20 so far today. Volume today is above average. So far 43,222,086 shares have traded compared to average volume of 11,105,979 shares. To screen for more stocks like Agile Therapeutics Inc click here.

More About Agile Therapeutics Inc

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. Click Here to get the full Stock Report for Agile Therapeutics Inc stock.